Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL9 | O00512 | 1/20 | 0.66 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.66 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.55 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.55 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | MGLL | Q99685 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | HGFAC | Q04756 | 1/20 | 0.49 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28122213 | 0.98 | BCL9 (0.64) | BCL9CTNNB1GAAKMT2APKM | |
| SCHEMBL7161403 | 0.86 | BCL9 (0.71) | BCL9CTNNB1GAAKMT2APKM | |
| SCHEMBL9967879 | 0.85 | BCL9 (0.70) | BCL9CTNNB1GAAKMT2APKM | |
| SCHEMBL957930 | 0.85 | BCL9 (0.81) | BCL9CTNNB1GAAKMT2APKM | |
| SCHEMBL11718045 | 0.84 | BCL9 (0.68) | BCL9CTNNB1GAAKMT2APKM | |
| SCHEMBL3749119 | 0.84 | BCL9 (0.68) | BCL9CTNNB1GAAKMT2APKM | |
| SCHEMBL7787947 | 0.83 | BCL9 (0.68) | BCL9CTNNB1GAAKMT2APKM | |
| SCHEMBL3422432 | 0.83 | BCL9 (0.55) | BCL9CTNNB1GAAKMT2APKM | |
| SCHEMBL3758383 | 0.83 | BCL9 (0.62) | BCL9CTNNB1GAAKMT2APKM | |
| SCHEMBL5370222 | 0.83 | BCL9 (0.67) | BCL9CTNNB1GAAKMT2APKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118079030-A | Drug-loaded polymer nano micelle and preparation method and application thereof | 郑州大学 | 2024-05-28 | — | — | CN | claimed |
| CN-104870603-A | Organic phosphorescent materials and methods for their preparation and use | EMPIRE TECHNOLOGY DEV LLC | 2015-08-26 | — | — | CN | claimed |
| CN-118079030-A | Drug-loaded polymer nano micelle and preparation method and application thereof | 郑州大学 | 2024-05-28 | — | — | CN | disclosed |
| CN-111039730-A | Waterproof formula of smokeless and sulfur-free firecracker nitrate medicament and preparation method thereof | 江西吉润花炮新材料科技有限公司 | 2020-04-21 | — | — | CN | disclosed |
| CN-106380415-B | A kind of preparation method of D, L- phenylglycine and the like | 宁夏紫光天化蛋氨酸有限责任公司 | 2019-01-22 | — | — | CN | disclosed |
| EP-3250040-A1 | METHOD | DuPont Nutrition Biosciences ApS (DK) | 2017-12-06 | — | — | EP | disclosed |
| CN-106380415-A | Preparation method for D, L-phenylglycine and analogue thereof | 宁夏紫光天化蛋氨酸有限责任公司 | 2017-02-08 | — | — | CN | disclosed |
| WO-2016123326-A1 | METHOD | DUPONT NUTRITION BIOSCIENCES APS (DK) | 2016-08-04 | — | — | WO | disclosed |
| CN-104870603-A | Organic phosphorescent materials and methods for their preparation and use | EMPIRE TECHNOLOGY DEV LLC | 2015-08-26 | — | — | CN | disclosed |
| CN-104356177-A | Pesticidal compositions | DOW AGROSCIENCES LLC | 2015-02-18 | — | — | CN | disclosed |
| CN-104163770-A | Method for extraction separation of 4-nitrobenzene glycine enantiomer by multistage centrifugal extractor | HUNAN INST SCIENCE & TECH | 2014-11-26 | — | — | CN | disclosed |
| EP-1453795-A2 | ESTERS AND AMIDES AS PPAR-ALPHA AGONISTS | Dr. Reddy's Laboratories Ltd. (IN) | 2004-09-08 | — | — | EP | disclosed |
| CN-1163619-C | Method and compositions for determining sequence of nucleic acid molecules | �Ѹ�������ѧ��˾ | 2004-08-25 | — | — | CN | disclosed |
| US-20030229083-A1 | Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them | DR. REDDY'S LABORATORIES LIMITED | 2003-12-11 | — | — | US | disclosed |
| WO-2003048116-A2 | ESTERS AND AMIDES AS PPAR-ALPHA AGONISTS ____________ | DR. REDDY'S LABORATORIES LTD. (IN) | 2003-06-12 | — | — | WO | disclosed |
| CN-1270598-A | Methods and compounds for analyzing nucleic acids by mass spectrometry | RAPIGENE INC (US) | 2000-10-18 | — | — | CN | disclosed |
| US-5998580-A | PROVIDING AN AMINO ACID INCLUDING A PHOTOLABILE MOLECULE AND INCORPORATING THE AMINO ACID INTO A PEPTIDE DURING SYNTHESIS, WHEREIN INCORPORATION OF THE AMINO ACID INTO THE PEPTIDE PRODUCES A PHOTOSENSITIVE PEPTIDE | NATIONAL INSTITUTES OF HEALTH, THE | 1999-12-07 | — | — | US | disclosed |
| CN-1212021-A | Method and compositions for determining sequence of nucleic acid molecules | RAPIGENE INC (US) | 1999-03-24 | — | — | CN | disclosed |
| CN-1212020-A | Method and compositions for analyzing nucleic acid molecules utilizing sizing techniques | RAPIGENE INC (US) | 1999-03-24 | — | — | CN | disclosed |
| WO-1997013782-A1 | PHOTOSENSITIVE CAGED MACROMOLECULES | UNIVERSITY OF MASSACHUSETTS MEDICAL CENTER (US) | 1997-04-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030229083-A1 | Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them | GPR119, LIPA, PCSK9 | BCL9 3332/4885CTNNB1 424/4885GAA 132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.